Standardization of in vitro digestibility and DIAAS method based on the static INFOGEST protocol

Background: The FAO recommends the digestible indispensable amino acid score (DIAAS) as the measure for protein quality, for which the true ileal digestibility needs to be assessed in humans or pigs. However, due to high costs and ethical concerns, the FAO strongly encourages as well the development of validated in vitro methods, which complement the in vivo experiments. Method: Recently, an in vitro workflow, based on the validated static INFOGEST protocol, was developed and compared towards in vivo data. In parallel to the validation with in vivo data, the repeatability and reproducibility of the in vitro protocol were tested in an international ring trial (RT) with the aim to establish an international ISO standard method within the International Dairy Federation (IDF). Five different dairy products (skim milk powder, whole milk powder, whey protein isolate, yoghurt, and cheese) were analyzed in 32 different laboratories from 18 different countries, across 4 continents. Results: in vitro protein digestibilities based on Nitrogen, free R-NH2, and total amino acids as well as DIAAS values were calculated and compared to in vivo data, where available. Conclusion: The in vitro method is suited for quantification of digestibility and will be further implemented to other food matricesinfo:eu-repo/semantics/publishedVersio

EuReCa ONE—27 Nations, ONE Europe, ONE Registry A prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe

AbstractIntroductionThe aim of the EuReCa ONE study was to determine the incidence, process, and outcome for out of hospital cardiac arrest (OHCA) throughout Europe.MethodsThis was an international, prospective, multi-centre one-month study. Patients who suffered an OHCA during October 2014 who were attended and/or treated by an Emergency Medical Service (EMS) were eligible for inclusion in the study. Data were extracted from national, regional or local registries.ResultsData on 10,682 confirmed OHCAs from 248 regions in 27 countries, covering an estimated population of 174 million. In 7146 (66%) cases, CPR was started by a bystander or by the EMS. The incidence of CPR attempts ranged from 19.0 to 104.0 per 100,000 population per year. 1735 had ROSC on arrival at hospital (25.2%), Overall, 662/6414 (10.3%) in all cases with CPR attempted survived for at least 30 days or to hospital discharge.ConclusionThe results of EuReCa ONE highlight that OHCA is still a major public health problem accounting for a substantial number of deaths in Europe.EuReCa ONE very clearly demonstrates marked differences in the processes for data collection and reported outcomes following OHCA all over Europe. Using these data and analyses, different countries, regions, systems, and concepts can benchmark themselves and may learn from each other to further improve survival following one of our major health care events

No adverse dietary effect of a cisgenic fire blight resistant apple line on the non-target arthropods Drosophila melanogaster and Folsomia candida

Genetic modification of apple cultivars through cisgenesis can introduce traits, such as disease resistance from wild relatives, quickly and without crossing. This approach was used to generate the cisgenic apple line C44.4.146, a 'Gala Galaxy' carrying the fire blight resistance gene FB_MR5. In contrast to traditionally bred apple cultivars, genetically modified (GM) plants need to undergo a regulatory risk assessment considering unintended effects before approval for commercial release. To determine potential unintended effects of C44.4.146, we assessed major leaf components and effects on the fitness of the decomposers Drosophila melanogaster (fruit fly) and Folsomia candida (collembolan), which were fed a diet amended with powdered apple leaf material. Leaf material of 'Gala Galaxy', several natural 'Gala' mutants, and the unrelated apple cultivar 'Ladina' were used for comparison. The genetic modification did not alter major leaf components and did not adversely affect survival, growth, or fecundity of the two decomposers. Consistent with previous studies with other GM crops, the differences between conventionally bred cultivars were greater than between the GM line and its non-GM wild type. These data provide a baseline for future risk assessments.ISSN:0147-6513ISSN:1090-241

Eosinophilic gastrointestinal disease suggestive of PR-10 allergy resolved after immunotherapy

status: publishe

In vitro digestibility of dietary proteins and in vitro DIAAS analytical workflow based on the INFOGEST static protocol and its validation with in vivo data

The FAO recommends the digestible indispensable amino acid score (DIAAS) to determine protein quality in foods, preferably tested in vivo. Here, the INFOGEST in vitro digestion protocol was applied and supplemented with an analytical workflow allowing the assessment of protein digestibility and DIAAS calculation. The protocol was applied to selected samples WPI, zein, collagen, black beans, pigeon peas, All-Bran®, and peanuts. The total protein digestibility, digestibility of individual amino acids (AA), and DIAAS values were established and compared with in vivo data for the same substrates. Total protein digestibility (total Nitrogen, r = 0.7, P < 0.05; primary amines (OPA), r = 0.6, P < 0.02; total AA, r = 0.6, P < 0.02) and digestibility of individual AA (r = 0.6, P < 0.0001) were in good agreement, between in vitro and in vivo, with a mean difference of 1.2 %. In vitro DIAAS was highly correlated with DIAAS obtained from in vivo true ileal digestibility values (r = 0.96, R2 = 0.89, P < 0.0001) with a mean difference of 0.1 %.IR acknowledges the project PID2019-107663RB-I00 funded by MCIN/AEI/10.13039/501100011033.Peer reviewe

Estimation of dairy goat body composition: A direct calibration and comparison of eight methods

International audienceThe objective was to compare eight methods for estimation of dairy goat body composition, by calibrating against chemical composition (water, lipid, protein, mineral and energy) measured post-mortem. The methods tested on 20 Alpine goats were body condition score (BCS), 3-dimension imaging (3D) automatic assessment of BCS or whole body scan, ultrasound, computer tomography (CT), adipose cell diameter, deuterium oxide dilution space (D 2 OS) and bioelectrical impedance spectroscopy (BIS). Regressions were tested between predictive variates derived from the methods and empty body (EB) composition. The best equations for estimation of EB lipid mass included BW combined with i) perirenal adipose tissue mass and cell diameter (R 2 = 0.95, residual standard deviation, rSD = 0.57 kg), ii) volume of fatty tissues measured by CT (R 2 = 0.92, rSD = 0.76 kg), iii) D 2 OS (R 2 = 0.91, rSD = 0.85 kg), and iv) resistance at infinite frequency from BIS (R 2 = 0.87, rSD = 1.09 kg). The D 2 OS combined with BW provided the best equation for EB protein mass (R 2 = 0.97, rSD = 0.17 kg), whereas BW alone provided a fair estimate (R 2 = 0.92, rSD = 0.25 kg). Sternal BCS combined with BW provided good estimation of EB lipid and protein mass (R 2 = 0.80 and 0.95, rSD = 1.27 and 0.22 kg, respectively). Compared to manual BCS, BCS by 3D slightly decreased the precision of the predictive equation for EB lipid (R 2 = 0.74, rSD = 1.46 kg), and did not improve the estimation of EB protein compared with BW alone. Ultrasound measurements and whole body 3D imaging methods were not satisfactory estimators of body composition (R 2 ≤ 0.40). Further developments in body composition techniques may contribute for high-throughput phenotyping of robustness

In vivo estimation of body composition: comparison of eight methods in dairy goats

International audienceThe objective was to test 8 methods for estimation of empty body lipid (EBL) and protein (EBP) mass in dairy goats. The methods tested on 20 Alpine goats (3±0.6 years old; 226±9 DIM; 47 to 72 kg of BW) were: adipose cell size; deuterium oxide dilution space (D2OS); 3-dimension (3D) imaging: whole body 3D-scan and automatic 3D assessment of body condition score (3D-BCS); manual sternal and lumbar BCS and ultrasound imagery; computer tomography and bioelectrical impedance spectroscopy (BIS). Simple and multiple regressions (Proc GLM, SAS) were tested between different variables and EBL and EBP mass measured by chemical analyses after slaughter. Perirenal adipose tissue mass and cell diameter combined with BW provided the most accurate predictive equations for EBL (R2=0.95, residual coefficient of variation, rCV=12%). Nonetheless, such predictors can only be measured postmortem. The best equations for EBL derived from in vivo variables included BW combined with 1/ the volume of fatty tissues measured by computer tomography (R2=0.92, rCV=17%), 2/ the D2OS (R2=0.91, rCV=19%), and 3/ the BIS (R2=0.87, rCV=23%). D2OS combined with BW provided the best equation for EBP (R2=0.97, rCV=3%), whereas BW alone provided a fair EBP estimate (R2=0.92, rCV=4%). Manual BCS combined with BW provided good EBL and EBP estimations (R2=0.80 and 0.94, rCV=28 and 4%, respectively). BCS is a non-invasive technique and does not require particular equipment, but it is subjective and prone to operator bias. Compared to manual BCS, 3D-BCS combined with BW slightly decreased the accuracy of the predictive equation for EBL (R2=0.74, rCV=32%), and did not improve the estimation of EBP compared with BW alone. Ultrasound and whole body 3D imaging techniques were not satisfactory estimators of EBL and EBP (R2≤0.40)

Standardization of in vitro digestibility and DIAAS method based on the static INFOGEST protocol

International audienceThe FAO recommends the digestible indispensable amino acid score (DIAAS) as the measure for protein quality, for which the true ileal digestibility needs to be assessed in humans or pigs. However, due to high costs and ethical concerns, the FAO strongly encourages as well the development of validated in vitro methods, which complement the in vivo experiments. Method: Recently, an in vitro workflow, based on the validated static INFOGEST protocol, was developed and compared towards in vivo data. In parallel to the validation with in vivo data, the repeatability and reproducibility of the in vitro protocol were tested in an international ring trial (RT) with the aim to establish an international ISO standard method within the International Dairy Federation (IDF). Five different dairy products (skim milk powder, whole milk powder, whey protein isolate, yoghurt, and cheese) were analyzed in 32 different laboratories from 18 different countries, across 4 continents. Results: in vitro protein digestibilities based on Nitrogen, free R-NH2, and total amino acids as well as DIAAS values were calculated and compared to in vivo data, where available. Conclusion: The in vitro method is suited for quantification of digestibility and will be further implemented to other food matrices

Search for high-mass exclusive diphoton production with tagged protons in proton-proton collisions at s= \sqrt{s} = 13 TeV

A search is presented for high-mass exclusive diphoton production via photon-photon fusion in proton-proton collisions at $\sqrt{s} =$ 13 TeV in events where both protons survive the interaction. The analysis utilizes data corresponding to an integrated luminosity of 103 fb$^{-1}$ collected in 2016--2018 with the central CMS detector and the CMS and TOTEM precision proton spectrometer (PPS). Events that have two photons with high transverse momenta ($p_{\mathrm{T}}^{\gamma} >$ 100 GeV), back-to-back in azimuth, and with a large diphoton invariant mass ($m_{\gamma\gamma} >$ 350 GeV) are selected. To remove the dominant inclusive diphoton backgrounds, the kinematic properties of the protons detected in PPS are required to match those of the central diphoton system. Only events having opposite-side forward protons detected with a fractional momentum loss between 0.035 and 0.15 (0.18) for the detectors on the negative (positive) side of CMS are considered. One exclusive diphoton candidate is observed for an expected background of 1.1 events. Limits at 95% confidence level are derived for the four-photon anomalous coupling parameters $|\zeta_1|$ 100 GeV), back-to-back in azimuth, and with a large diphoton invariant mass ($m_{\gamma\gamma} \gt$ 350 GeV) are selected. To remove the dominant inclusive diphoton backgrounds, the kinematic properties of the protons detected in PPS are required to match those of the central diphoton system. Only events having opposite-side forward protons detected with a fractional momentum loss between 0.035 and 0.15 (0.18) for the detectors on the negative (positive) side of CMS are considered. One exclusive diphoton candidate is observed for an expected background of 1.1 events. Limits at 95% confidence level are derived for the four-photon anomalous coupling parameters $\lvert\zeta_1\rvert \lt$ 0.073 TeV$^{-4}$ and $\lvert\zeta_2\rvert \lt$ 0.15 TeV$^{-4}$, using an effective field theory. Additionally, upper limits are placed on the production of axion-like particles with coupling strength to photons $f^{-1}$ that varies from 0.03 TeV$^{-1}$ to 1 TeV$^{-1}$ over the mass range from 500 to 2000 GeV